{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:28:57Z","timestamp":1758814137239,"version":"3.41.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:ddas.0000007859.10680.b1","type":"journal-article","created":{"date-parts":[[2003,12,13]],"date-time":"2003-12-13T08:10:55Z","timestamp":1071303055000},"page":"2247-2256","source":"Crossref","is-referenced-by-count":15,"title":["Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Gastric Fibroblasts and Effects of Nonsteroidal Antiinflammatory Drugs and Prostaglandin"],"prefix":"10.1007","volume":"48","author":[{"given":"Jun-Ichi","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Otsubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syuuhei","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Narasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Omata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Shimokoube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"479251_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00001721-199102000-00007","volume":"2","author":"D Reilly","year":"1991","unstructured":"Reilly D, Andreasen PA, Duffy MJ: Urokinase-plasminogen activator in breast cancer: assay by both catalytic and immunoassay. Blood Coagul Fibrinolysis 2:47-50, 1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"479251_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcla.1860090613","volume":"9","author":"S Miseljic","year":"1995","unstructured":"Miseljic S, Galandiuk S, Myers SD, Wittliff JL: Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease. J Clin Lab Anal 9:413-417, 1995","journal-title":"J Clin Lab Anal"},{"key":"479251_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0748-7983(96)91649-2","volume":"22","author":"MM Heiss","year":"1996","unstructured":"Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U, Schildberg FW: The prognostic impact of the urokinase-type plasminogen activator system is associated with tumor differentiated in gastric cancer. Eur J Surg Oncol 22:74-7, 1996","journal-title":"Eur J Surg Oncol"},{"key":"479251_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<878::AID-CNCR2>3.0.CO;2-8","volume":"79","author":"JY Cho","year":"1997","unstructured":"Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS: High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 79:878-83, 1997","journal-title":"Cancer"},{"key":"479251_CR5","first-page":"2234","volume":"58","author":"G De Petro","year":"1998","unstructured":"De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S: Expression of urokinase-type plasminogen activator, u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. Cancer Res 58:2234-2239, 1998","journal-title":"Cancer Res"},{"key":"479251_CR6","first-page":"843","volume":"92","author":"L Hersz\u00e8nyi","year":"1997","unstructured":"Hersz\u00e8nyi L, Plebani M, Carrao P, De Paoli M, Cardin R, Di Mario F, Kusstatscher S, Naccarato R, Farinati F: Impaired fibrinolysis and increased pretease levels in gastric and duodenal mucosa of patients with active duodenal ulcer. Am J Gastroenterol 92:843-847, 1997","journal-title":"Am J Gastroenterol"},{"key":"479251_CR7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/gut.34.10.1310","volume":"34","author":"MA Wodzi\u0144ski","year":"1993","unstructured":"Wodzi\u0144ski MA, Bardhan KD, Reilly JT, Cooper P, Preston FE: Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease. Gut 34:1310-1314, 1993","journal-title":"Gut"},{"key":"479251_CR8","first-page":"47","volume":"275","author":"K Takahashi","year":"1998","unstructured":"Takahashi K, Uwabe Y, Sawasaki Y, Kiguchi T, Nakamura H, Kashiwabara K, Yagyu H, Matsuoka T: Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells. Am J Physiol 275:47-54, 1998","journal-title":"Am J Physiol"},{"key":"479251_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1172\/JCI115405","volume":"88","author":"JD Vassalli","year":"1991","unstructured":"Vassalli JD, Sappino A, Belin D: The plasmonigen a activator\/plasmin system. J Clin Invest 88:1067-1072, 1991","journal-title":"J Clin Invest"},{"key":"479251_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0065-230X(08)60028-7","volume":"44","author":"K Dano","year":"1985","unstructured":"Dano K, Andreasen PA, Gronbahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266, 1985","journal-title":"Adv Cancer Res"},{"key":"479251_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.104.4.801","volume":"104","author":"F Blasi","year":"1987","unstructured":"Blasi F, Vassalli J, Dano K: Urokinase-type plasminogen activator, proenzyme, recepter, and inhibitors. J Cell Biol 104:801-804, 1987","journal-title":"J Cell Biol"},{"key":"479251_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0049-3848(88)90201-0","volume":"50","author":"N Nishino","year":"1988","unstructured":"Nishino N, Aoki K, Tokura Y, Sakaguchi S, Takada Y. Takada A: The urokinase type of plasminogen activator in cancer of digestive tracts. Thromb Res 50:527-535, 1988","journal-title":"Thromb Res"},{"key":"479251_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1074\/jbc.270.2.603","volume":"270","author":"L Naldini","year":"1995","unstructured":"Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM: Biological activation of pro-HGF by urokinase is controlled by a stoichiometric reaction. J Biolog Chem 270:603-611, 1995","journal-title":"J Biolog Chem"},{"key":"479251_CR14","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1002\/j.1460-2075.1992.tb05588.x","volume":"11","author":"L Naldini","year":"1992","unstructured":"Naldini L, Tamagnone L, Vigna E, Sschs M, Hartmann G, Birchmeier W: Extracallular proteolytic cleavage by uroknase is required for activation of hepatocyte growth factor. EMBO J 11:4825-4833, 1992","journal-title":"EMBO J"},{"key":"479251_CR15","first-page":"1001","volume":"17","author":"Y Okusa","year":"2000","unstructured":"Okusa Y, Ichikura T, Mochizuki H, Shinomiya N: Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines. Int J Oncol 17:1001-1005, 2000","journal-title":"Int J Oncol"},{"key":"479251_CR16","first-page":"4629","volume":"41","author":"LA Liotta","year":"1981","unstructured":"Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41:4629-4636, 1981","journal-title":"Cancer Res"},{"key":"479251_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00124214","volume":"1","author":"PA Jones","year":"1982","unstructured":"Jones PA, De Clerck YA: Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev 1:289-317, 1982","journal-title":"Cancer Metastasis Rev"},{"key":"479251_CR18","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1172\/JCI119080","volume":"98","author":"M Takahashi","year":"1996","unstructured":"Takahashi M, Ota S, Hata Y, Mikima Y, Azuma N, Nakamura T, Terano A: Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 98:2604-2611, 1996","journal-title":"J Clin Invest"},{"issue":"Suppl1","key":"479251_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1365-2036.2000.014s1044.x","volume":"14","author":"M Takahashi","year":"2000","unstructured":"Takahashi M, Katayama Y, Takada H, Kuwayama H, Terano A: The effect of NSAIDs and a cox-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts. Aliment Pharmacol Ther 14 (Suppl 1):44-49, 2000","journal-title":"Aliment Pharmacol Ther"},{"key":"479251_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/bbrc.1998.8436","volume":"245","author":"H Bamba","year":"1998","unstructured":"Bamba H, Ota S, Kato A, Matsuzaki F: Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 245:567-571, 1998","journal-title":"Biochem Biophys Res Commun"},{"key":"479251_CR21","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1016\/S0021-9258(18)55433-8","volume":"15","author":"PHA Quax","year":"1990","unstructured":"Quax PHA, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Barkel TJC, Kuiper J, Emeis JJ: Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 15:15560-15563, 1990","journal-title":"J Biol Chem"},{"key":"479251_CR22","first-page":"427","volume":"50","author":"MJ Niedbala","year":"1991","unstructured":"Niedbala MJ, Stein M: Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells. Biomed Biochim Acta 50:427-436, 1991","journal-title":"Biomed Biochim Acta"},{"key":"479251_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000468621","volume":"49","author":"P Mignatti","year":"1996","unstructured":"Mignatti P, Rifkin DB: Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117-137, 1996","journal-title":"Enzyme Protein"},{"key":"479251_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF01255603","volume":"19","author":"DCH Sun","year":"1974","unstructured":"Sun DCH, Roth SH, Mitchell CS: Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis Sci 19:405-410, 1974","journal-title":"Dig Dis Sci"},{"key":"479251_CR25","first-page":"656","volume-title":"Bockus Gastroenterology","author":"CJ Hawkey","year":"1995","unstructured":"Hawkey CJ, Hudson N: Mucosal injury caused by drugs, chemicals, and stress. In Bockus Gastroenterology, 5th ed, vol, 1995, pp 656-699, Saunders, Philadelphia.","edition":"5th ed"},{"key":"479251_CR26","first-page":"1153","volume":"82","author":"EN Larkai","year":"1987","unstructured":"Larkai EN, Lacey Smith J, Lidsky MD: Gastroduodenal mucosa and dtspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 82:1153-1158, 1987","journal-title":"Am J Gastroenterol"},{"key":"479251_CR27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231:232-235, 1971","journal-title":"Nature New Biol"},{"key":"479251_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0090-6980(85)90025-5","volume":"30","author":"K Kobayashi","year":"1985","unstructured":"Kobayashi K, Arakawa T, Satoh H, et al: Effect of indomethacin, tiaprofenic acid, and dicrofenic acid, and dicrofenac on rat gastric mucosal damage and content of prostacyclin and prostaglandin E2. Prostaglandins 30:609-618, 1985","journal-title":"Prostaglandins"},{"key":"479251_CR29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(79)90235-X","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A: Cytoprotection by prostaglandins. Gastroenterology 77:761-767, 1979","journal-title":"Gastroenterology"},{"key":"479251_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.bjp.0701673","volume":"123","author":"B Gretzer","year":"1998","unstructured":"Gretzer B, Ehrlich K, Maricic N: Selective cyclooxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rar stomach. Br J Pharmacol 123:927-935, 1998","journal-title":"Br J Pharmacol"},{"key":"479251_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","volume":"112","author":"H Mizuno","year":"1997","unstructured":"Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397, 1997","journal-title":"Gastroenterology"},{"key":"479251_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/gut.46.6.782","volume":"2000","author":"A Tatsuguchi","year":"2000","unstructured":"Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S: Localisation of cyclooygenase 1 and 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000:782-789, 2000","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000007859.10680.b1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000007859.10680.b1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000007859.10680.b1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:24:18Z","timestamp":1753759458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000007859.10680.b1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["479251"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000007859.10680.b1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}